Funding for this research was provided by:
National Natural Science Foundation of China (82002220, 12026601, 81902762)
Received: 12 September 2021
Accepted: 26 October 2022
First Online: 29 November 2022
: The current research was approved by the Research Ethics Committee of Sun Yat-sen University Cancer Center (SYSUCC). All methods were performed in accordance with the relevant guidelines and regulations. As our study was based on an analysis of patients’ routine clinical and treatment data, the research ethics committees of SYSUCC waived the requirement for individual informed consent.
: There are no details on individuals reported within the manuscript.